Home / Brands / Central Admixture Pharmacy Services
Central Admixture Pharmacy Services Recalls
347 recalls on record · September 3, 2014 to August 12, 2026 · Drugs
Recalls by year
14
15
23
25
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in Dextrose 5%, 0.5 mg/5 mL (0.1 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, S
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls succinylcholine, 200 mg/10 mL, (20 mg/mL), 10 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, C
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Serv
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 500 mcg/50 mL, (10 mcg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Service
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 100 mcg/10 mL, (10 mcg/mL), 10 mL Syringe, Rx only, Central Admixture Pharmacy Service
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone added to 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 100 mL bag, Rx only, Central Admixture Pharmacy S
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 5000 mcg/100 mL, (50 mcg/mL), 100 mL Bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Ro
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 100 mL bag, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in dextrose 5%, 3 mg/30 mL, (0.1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc.
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls vecuronium, 10 mg/10mL, (1 mg/mL), 10 mL syringe, Rx only, PARALYZING AGENT, CAPS, Inc., 7935 Dunbrook Road, Suite C, Sa
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Roa
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 100 mcg/2 mL, (50 mcg/mL), 3 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Roa
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% sodium chloride, 6 mg/30 mL, (0.2 mg/mL), 30 mL Syringe, Rx only, CAPS, Central Admixture Pharmacy
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 1250 mcg/25 mL, (50 mcg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in dextrose 5%, 300 mcg/30 mL, (10 mcg/mL), 30 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc.,
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION, 24 mEq K, Maintenance 8:1 non-enriched, Low Potassium, IV Bag, Total Volume = 300 mL, RX only, Ce
Hazard: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION, 24 mEq K, Maintenance 8:1, Low Potassium, IV Bag, total volume = 500 mL, Rx only, Central Admixtu
Hazard: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION, 36 mEq K, Maintenance 8:1, low Potassium / low dextrose, IV Bag, total volume = 500 mL, Rx only,
Hazard: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION, low K, Maintenance 4:1 Plasmalyte/Tromethamine, Low Potassium, IV Bag, total volume = 1000 mL, Rx
Hazard: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, low K, Maintenance 4:1 Plasmalyte, Low Potassium, IV Bag, total volume = 1047 mL, Rx only, Centr
Hazard: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION, 20 mEq K, Maintenance 4:1, Low Potassium, IV Bag, total volume = 810 mL, Rx only, Central Admixt
Hazard: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION, 12 mEq K, Maintenance 4:1 in Ringer's Low Potassium, IV Bag, total volume = 504.8 mL, Rx only, Ce
Hazard: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION, 70 mEq K, Induction 8:1, non-enriched, High Potassium, IV Bag, Total Volume = 300 mL, RX only, C
Hazard: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION, 70 mEq K, Modified St. Thomas Formula low potassium, IV Bag, Total Volume = 1000 mL, Rx only, Cen
Hazard: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION, 108 mEq K, Induction 8:1, High Potassium, IV Bag, total volume = 500 mL, Central Admixture Pharma
Hazard: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION, 100 mEq K, Induction 8:1, High Potassium / Low dextrose, IV Bag, total volume = 500 mL, RX Only,
Hazard: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION 122 mEq K, Modified St. Thomas Formula High Potassium, Total Volume = 1000 mL, IV Bag, Rx only, Ce
Hazard: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION, 106 mEq K, Modified St. Thomas Solution High Potassium High Sodium Bicarbonate, IV Bag, Total Vo
Hazard: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION, 60 mEq K, Induction 4:1, High Potassium, IV Bag, total volume = 830 mL, Central Admixture Pharmac
Hazard: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.